Geneva Health Forum Archive

Browse and download abstracts, posters, documents and videos from past editions of the GHF

Geneva Health Forum 2014 – Conclusions of Day 2

Highlight_of_the_Day Highlights of the Day

  • For integration of health to become a reality the following are needed:
    • Enlightened politicians
    • Multiple sectors and actors involved in health (but being careful of any conflicts of interest)
    • Adequate funding and resources and appropriate use of these
    • Research and production of knowledge

Lesson_of_the_day Lessons of the Day

  • How does the global governance structure help ensure integration of health and the health system by:
    • Leading at a global level, but taking into account local conditions
    • Define the roles and responsibilities of different actors
    • Ensure coherent allocation of resources
    • Make health the priority and entry point for sustainable future

Quote of the day1 Quote of the day2 Quote of the Day

“ Stop talking about health systems and start talking about systems for health” - D. De Savigny, Head, Health Systems Interventions Research Unit, Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Switzerland

Feedback Feedback

  • Integration seems to mean different things to different people
  • This brings things I have read and learnt to life
  • Amazing panel with Prof. Ilona Kickbush, Prof. Ronald Labonté, Dr. Mira Shiva, Mr. Pascal Lamy and Mr. Bart Peterson – such a wealth of information
  • All the speakers are so approachable and open to further discussion and debate after their presentations

Unanswered_Question Unanswered Question

  • Day 1 looked at the “what” of integration and Day 2 more about the “how” so the unanswered questions are:
    • Who will lead the integration agenda?
    • What role for the WHO in the changing global health environment?
    • What role for the private sector in integration?

Lesson  Expectations for Tomorrow

  • Looking at issues beyond health, e.g. food, innovation, sustainability
  • How can integrating other sectors and perspectives benefit health
  • More interesting and thought provoking sessions

Download here the PDF version for CONCLUSIONS of DAY 2

 

 

 

Dr. Anne Golaz

Golaz-AnneDr. Anne Golaz

Lecturer and Researcher at CERAH, Switzerland

She obtained her Medical Doctor degree and Doctorate in Medicine at the University of Geneva, and a MPH at the University of Washington. She’s Board Certified in Public Health and General Preventive Medicine. She has over 20 years of field experience in humanitarian work and graduate and post-graduate education in public health. She’s worked as a medical epidemiologist for the US Centers for Disease Control and Prevention; as a senior advisor for UNICEF Regional Office for South Asia in Kathmandu and Geneva Office, and for WHO HQ and Regional Offices in Cairo and New Dehli.

Role at the CERAH:

  • Member of the Scientific Committees of the CAS Health in Humanitarian Emergencies and CAS Disaster Management
  • Coordinator CAS Health in Humanitarian Emergencies
  • Coordinator of the Research Methodology course (MAS-DAS)
  • Co-leader of the course Health Interventions in Humanitarian Crises (MAS-DAS week)
  • Co-leader TS Advocacy for Humanitarian Projects in Health

Fields of interest:

  • Public health and epidemiology
  • Reproductive health in humanitarian emergencies
  • Mental health in humanitarian emergencies
  • Genocide prevention
  • Community capacity building
  • Research and evidence generation in humanitarian contexts

Dr. Marie-Claude Bottineau

PS12_Dr_Marie_BottineauDr. Marie-Claude Bottineau

Pediatrician, Neonatology, Pediatrics Intensive Care, MSF CH, Geneva, Switzerland

Dr. Bottineau is a French Pediatrician with a DESS in Neonatology, a competency in Pediatrics Intensive Care and a Master Degree in Public Health and Tropical Medicine. She did the first part of her carrier working in General and University Hospitals in France as Pediatrician in Pediatrics, Pediatrics and Neonatal Intensive Care in Nantes, Nancy, Le Havre and Paris and her Tropical Medicine Degree in Pitié Salpêtrière Hospital, Paris, with Pr Gentilini and Pr Duflo. She also studied Bio-Ethics in Paris as free auditor getting an equivalence of Master Degree.

In parallel, she was doing some regular missions around the world with several Humanitarian Organizations including MSF- France in Kosovo; Vietnam (Ho-Chi-Minh); Madagascar (Antananarivo); Nicaragua (Leon and Managua), during civil war; Nepal (Pokhara-Jomoson); India (Calcutta, slums of Howrah-Pilkhana) and Cameroon (Mpoundou, Abong-Mbang district).

From 1990 to 1996, she dedicated her carrier to the humanitarian action working exclusively in expatriation in different humanitarian contexts of which in Benin with Terre Des Hommes-Lausanne and in Angola with MSF-France (Uige and Benguela provinces during civil war).

After an urgent medical repatriation in December 1995, time for recovering, few months in HQ MSF-France in Paris and few years in Robert Debré Hospital (Pediatrics Emergencies and Neonatal SMUR), she was to the United States in order to complete her Master Degree in Public Health (2000). Then, she worked 2 years as Public Health Medical Specialist at CRED (Center for Research on the Epidemiology of Disasters), UCL, Brussels, Belgium. At the same time she made several missions to Cambodia for the Belgium Cooperation and some consultancies as Evaluator within the European Commission for INCO-DEV and INCO-MED programs.

From 2001 to 2003 she made regular consultancies for WHO Geneva in Switzerland (Geneva) on GAVI (Global Alliance for Vaccines & Immunizations); Chad (Tanjile), Mali (Bamako) and Indonesia (Djakarta, Bali and Iles de la Sonde) on Maternal and Neonatal Tetanus Elimination (MNTE) including Lot Quality Assurance Surveys (LQAS).

From January 2003 to July 2007 she worked as UNHCR Senior Regional Health/Nutrition/HIV – AIDS Co-ordinator for West Africa based in Sierra Leone (Freetown) and Ghana (Accra), then the Great Lakes Region based in Burundi (Bujumbura) and at least Chad – Darfour Emergency, based in Chad (Abéché).

Mid July 2007, she was appointed as Pediatrics Referent in MSF-CH to develop pediatrics vision, policy and strategic approach and to give adequate support to pediatrics fields. In April 2011, she took the coordination and leadership of the MSF International Pediatrics Working Group and early 2014 the coordination of the Mother, Neonatal and Child pool including nutrition.

She taught extensively (H.E.L.P Course, in MSF, UNHCR, Universities...) and participated actively in international congresses making some abstracts, publications, posters, and/or oral communications.

She contributed for many years to the work of Amnesty International against Torture, acting with the Medical Commission. After different professional affiliations, she is currently active member of the Target Advisory Group (TAG) of the International Pediatrics Association (IPA) on Children in Humanitarian Disasters, of the Partnership for Maternal, Newborn and Child Health (PMNCH) (WHO, UNICEF, Save The Children...) and of the Group of Tropical Pediatrics (Société Francaise de Pédiatrie).

She got certificates of recognition from CDC Atlanta, H.E.L.P Course and the UNAM of Nicaragua for her action in emergency settings and/or her contribution to the teaching.

GHF 2014 – PS01

10:45
12:15
PS01 TUESDAY, 15 APRIL 2014 ROOM: MOTTA ICON_Fishbowl
Public Hospitals Can Innovate Too!
MODERATORS:
Prof. Louis Loutan
Former head of the division of International and Humanitarian Medicine at the Geneva University Hospitals
Prof. Didier Pittet
Head of the infection control unit and president of the commission on innovation at the Geneva university Hospitals
SPEAKERS:
Prof. Brigitte Pittet
Chief of Division, Geneva University Hospitals, Switzerland
Prof. François Mach
Chief of Division, Geneva University Hospitals, Switzerland
Prof. Patrick Petignat
Chief of Division, Geneva University Hospitals, Switzerland
Ms. Anne Bourgeois
Physiotherapist, Geneva University Hospitals, Switzerland
Prof. François Chappuis
Chief of Division, Geneva University Hospitals, Switzerland
Dr. François Gilardoni
World Innovation Day, Innovation 4 Health, co-founder Special Advisor at Fongit Seed Invest, Switzerland
OUTLINE:
Public institutions often convey the image of being slow in responding to needs, plagued by inertia and leaving innovation to the private sector. This session will illustrate through numerous examples of projects implemented locally or abroad that innovation can be integrated in the overall strategy development of a public institution, such as a university hospital. It brings added value to the institution, strengthens its reputation, motivates its employees and retains them, it creates public value and a sense of satisfaction. Innovation can be built in at all levels of the institution and become a driving force. Partnerships with institutions abroad also play a significant role in developing and sharing new expertise, values and social responsibility.
PROFILES:

Prof. Louis LoutanProf. Louis Loutan

Louis is the founder of the Geneva Health Forum and has been its President since 2006. In this capacity Louis is responsible for providing strategic guidance to the initiative and ensures that it continues to enjoy wide institutional support.

Louis is Head of the Division of International and Humanitarian Medicine in the Department of Community Medicine and Primary Care and a practicing clinician at the Geneva University Hospitals in Geneva, Switzerland. He also serves the University of Geneva as Associate Professor in International and Humanitarian Medicine.

Louis is a specialist in internal medicine and tropical medicine. Louis has extensive field experience in Africa, Asia, North America and Eastern Europe. Louis is the former president of the Swiss Society of Tropical Medicine and Parasitology; President of the International Society of Travel Medicine (2001-2003). He serves on the boards of public and academic organisations that are committed to advancing the cause of global access to health.

ProfPittet(2-Black)Prof. Didier Pittet

Didier Pittet, MD, MS, is the Hospital Epidemiologist and the Director of the Infection Control Programme at the University of Geneva Hospitals and Clinics (2500 beds), Geneva, Switzerland; Professor of Medicine and Hospital Epidemiology at the University of Geneva; and Attending Physician in Adult and Paediatric Infectious Diseases, University of Geneva Hospitals. He is also Visiting Professor, Division of Investigative Sciences and School of Medicine, Imperial College London, London, UK. Professor Pittet serves on the editorial boards of the American Journal of Infection Control, the American Journal of Respiratory and Critical Care Medecine, The Lancet Infectious Diseases and Infection Control and Hospital Epidemiology. He is also an editorial consultant of the Lancet. Professor Pittet currently leads the First Global Patient Safety Challenge “Clean Care is Safer Care” of the WHO World Alliance for Patient Safety. He was awarded the CBE in 2007 by Her Majesty Queen Elisabeth II for services to the prevention of healthcare-associated infection in the UK. Current major research interests include the epidemiology and prevention of nosocomial infections, methods for improving compliance with hand hygiene practices, and methods for improving the quality of patient care and patient safety.

PS01_Brigitte_PittetProf. Brigitte Pittet

Prof. Brigitte Pittet est médecin-cheffe du service de Chirurgie plastique, reconstructive et esthétique des Hôpitaux Universitaires de Genève. Ses principaux domaines d’intérêt sont la reconstruction craniofaciale et la reconstruction mammaire ainsi que les techniques de microchirurgie. Prof. Pittet organise régulièrement des missions humanitaires chirurgicales dédiées au traitement des séquelles de noma. Elle a reçu plusieurs distinctions pour ses activités de recherche axées sur la cicatrisation des plaies.

PS01_Patrick PetignatProf. Patrick Petignat

Prof. Petignat and his research group have experience in running clinical trials and epidemiological studies in the field of cervical cancer and HPV. They are also involved in the development of screening policy and colposcopy practice for the Groupement Romand de la Société Suisse de Gynécologie Obstétrique (GRSSO). They have recently developed and published consensus
guideline for cervical cancer screening and management of cervical dysplasia for the Swiss French Part (available at www.GRSSGO.ch). Patrick Petignat is a co-founder of the Swiss Working Group for
Colposcopy and Cervical Pathology and is member of the WHO Steering Committee on Comprehensive Cervical Cancer Control (C4-GEP).

chappuis_photo_3Prof. François Chappuis

François Chappuis is physician specialized in internal and tropical medicine. He completed a master in clinical tropical medicine at Mahidol University, Bangkok and a PhD in medical sciences at the University of Antwerp. He currently heads the division of tropical and humanitarian medicine of the Geneva University Hospitals and has been medical adviser for neglected tropical diseases at Médecins sans Frontières since 1999. His clinical research activities focus on African and American trypanosomiasis, leishmaniasis and snake bites.

PS01_Francois.Gilardoni.SmallPicMr. François Gilardoni

Francois Gilardoni is a venture capitalist, innovation expert and award-winning scientist educated in Switzerland and the USA with nearly two decades of international experience in the high-tech and financial industries.  Building on the success of the first Innovation Day (ID) held in Geneva in 2007, in 2012 he partnered with Professor Didier, ID founder and world renowned specialist in patient safety, to foster a global culture of innovation in Medical and Healthcare Science by promoting Innovation Days around the world.  In 2013, they launched the World Innovation Day (WID) and the World Innovation Academy (WIA) global initiatives. Francois holds a PhD (cum laude) in Computational Chemistry, as well as advanced degrees in Environmental Science and Computing.  He is the founder of Global Advisory Services (GlobAS), a boutique firm providing non-discretionary investment advisory services to clients seeking to expand their private equity portfolio in the high-tech industry and to ventures raising capital (debt or equity).

PS01_Anne_Bourgeois_HUG_squareMs. Anne Bourgeois

Anne Bourgeois graduated as a physiotherapist in Geneva. After some time in the private sector, she joined the Geneva University Hospitals in 2002, where she worked in various departments, in acute care and rehabilitation services. She has extensive experience in numerous humanitarian projects providing care and training local staff as trainers (South of Marocco 2002, Haiti 2010 with Handicap International (HI) and MSF, Yemen with ICRC 2012-2013). She currently is involved in a training in rehabilitation project in Haiti with HI.

PS01_Francois_Mach_006Prof. François Mach

Prof. François Mach has extensive experience in the field of Cardiology particularly, with respect to the development and progression of atherosclerosis diseases. After obtaining his MD at the University of Geneva, he studied Internal Medicine and Cardiology at Geneva University Hospital. Then, he moved for post-doctoral fellowship in the laboratory of Professor Peter Libby, Brigham and Women’s Hospital, Boston (1995-1999). After his return in 2000, he became full Professor of Cardiology and Head of Cardiology at the Geneva University Hospital. From 2012, he is President of the Swiss Society of Cardiology. François Mach is author of more than 250 publications with high Impact Factor and during his career he has already obtained more than 5 million euros as research grants, all funded by the European Community.

Prof. Mach is the director of the Cardiology Laboratory at School of Medicine of the University of Geneva that offers a number of general facilities.

His research group developed animal models of atherosclerosis, acute myocardial infarction, chronic myocardial ischemia and ischemic stroke. Several knockout mice on inflammatory genes are available in the Cardiovascular Center. In the last 10 years, the group of Prof Mach substantially contributed to better clarify the inflammatory mechanisms underlying atherosclerosis and its acute dramatic complications, such myocardial infarction and ischemic stroke in both human cohort and animal studies. In addition, he contributed to the design and achievement of several clinical research, multi-center studies, as well as establishment of several cohorts of CVD patients

 

 

 

GHF2014 – PS14 – Integrating Sexual and Reproductive Health Care in Humanitarian Interventions

16:00
17:30
PS14 TUESDAY, 15 APRIL 2014 ROOM: 18 ICON_Fishbowl
Integrating Sexual and Reproductive Health Care in Humanitarian Interventions
MODERATOR:
Dr. Doris Schopper
Professor at the medical faculty of the University of Geneva and director of CERAH, Switzerland
SPEAKERS:
Dr. Anne Golaz
Lecturer and researcher at CERAH, Switzerland
Ms. Wilma Doedens
Technical Adviser on Reproductive Health in Emergencies, Humanitarian Response, UNFPA, Switzerland
Dr. Lisa Thomas
Medical Officer, Department of Reproductive Health and Research, World Health Organization, Switzerland
Ms. Nelly Staderini
Référente médicale- Santé de la reproduction, Reproductive Health Advisor, MSF, Switzerland
OUTLINE:
Problems related to sexual and reproductive health are the leading cause of death and ill health for women of childbearing age globally. In crises, this vulnerability increases, while access to services decreases. The urgent need for life-saving sexual and reproductive health services has often been neglected and not prioritized in humanitarian responses.  Speakers from UN agencies and INGOs will give a brief overview of some of their sexual and reproductive health programmes, discuss recent achievements, challenges in integrating sexual and reproductive healthcare in humanitarian interventions and ways to advocate for better access to these services during crises.
PROFILES:

SCHOPPER-DorisDr. Doris Schopper
Professor at the medical faculty of the University of Geneva and director of CERAH, Switzerland

She obtained a medical degree at the University of Geneva (1978), trained as a specialist in Internal Medicine (1986) and completed a Doctor in Public Health at the Harvard School of Public Health (1992).

Between 1982 and 1990 Doris Schopper spent several years with Médecins Sans Frontières (MSF) in the field. She was president of the Swiss branch of MSF (1991–1998) and twice president of the MSF International Council during this period. In 2001 Doris Schopper was asked to constitute an Ethics Review Board for MSF International.

Since then she has chaired the Board coordinating the ethical review of MSF research proposals and providing advice on ethical matters to the organisation.

Doris Schopper also worked as health policy adviser in the Global Programme on AIDS at WHO headquarters in Geneva (1992-95).

Further international work includes two years as senior health policy adviser at the Swiss Tropical Institute and developing several policies and strategies for WHO (e.g. guideline for policy makers on national policies for violence and injury prevention; strategy for mother-to-child transmission of HIV in Europe; WHO-wide strategy on child and adolescent health).

Professor Schopper has also been responsible for the development of health policies and strategies at the national and regional level in Switzerland (e.g. Swiss National Cancer Control Programme 2005-2010; framework to prevent obesity at the national level; comprehensive health policy for the canton of Geneva). She is member of the board of Pro Victimis Foundation-Geneva since 2003, and president since 2010.

In November 2012, Doris Schopper was appointed member of the International Committee of the Red Cross (ICRC).

Functions:

  • Director
  • Member of the Scientific Committees of the CAS
  • Coordinator CAS Health in Humanitarian Emergencies
  • Co-responsible Course Health Interventions in Humanitarian Crises

Fields of Interest:

  • Public health in humanitarian contexts
  • Development and analysis of health policy
  • Research ethics in humanitarian contexts
  • Ethics of humanitarian medical intervention
  • HIV-Aids, Cancer

 

Golaz-AnneDr. Anne Golaz
Lecturer and researcher at CERAH, Switzerland

She obtained her Medical Doctor degree and Doctorate in Medicine at the University of Geneva, and a MPH at the University of Washington. She’s Board Certified in Public Health and General Preventive Medicine. She has over 20 years of field experience in humanitarian work and  graduate and post-graduate education in public health. She’s worked as a medical epidemiologist for the US Centers for Disease Control and Prevention; as a senior advisor for UNICEF Regional Office for South Asia in Kathmandu and Geneva Office, and for WHO HQ and Regional Offices in Cairo and New Dehli.

Role at the CERAH

  • Member of the Scientific Committees of the CAS Health in Humanitarian Emergencies and CAS Disaster Management
  • Coordinator CAS Health in Humanitarian Emergencies
  • Coordinator of the Research Methodology course (MAS-DAS)
  • Co-leader of the course Health Interventions in Humanitarian Crises (MAS-DAS week)
  • Co-leader TS Advocacy for Humanitarian Projects in Health

Fields of interest

  • Public health and epidemiology
  • Reproductive health in humanitarian emergencies
  • Mental health in humanitarian emergencies
  • Genocide prevention
  • Community capacity building
  • Research and evidence generation in humanitarian contexts

 

Ms. Wilma Doedens

Wilma Doedens is the Technical Adviser on Reproductive Health in Emergencies of the Humanitarian Response Branch of UNFPA. She has worked with UNFPA since 2002. Prior to this she worked with WHO.

Wilma is a Medical Doctor with a public health and reproductive health background. She has extensive field experience in coordinating and implementing reproductive health services in both humanitarian and development settings, working within national health systems as well as with NGOs such as Medecins Sans Frontieres (MSF), International Rescue Committee (IRC) and the International Federation of the Red Cross (IFRC).

She coordinated the writing and publication of the Inter-Agency Field Manual for Reproductive Health in Humanitarian Settings and the Inter-Agency Standing Committee Gender-Based Violence Guidelines, and she is responsible for ensuring technical review and quality improvement of the Inter-Agency Reproductive Health Kits designed to support the implementation of priority reproductive health interventions in disasters.

 

Dr. Lisa Thomas

Lisa Thomas, MD is a Medical Officer in the Department of Reproductive Health and Research at the World Health Organization in Geneva, where she serves as the focal point for sexual and reproductive health in humanitarian settings.  She is a U.S. Board Certified Obstetrician Gynecologist with subspecialty training in family planning. Prior to joining WHO, she worked for humanitarian, development and donor agencies in over twenty developing countries including conflict and post-conflict settings. She has covered an expansive breadth of public and private sector projects in maternal and reproductive health policy, program design, training, research and monitoring and evaluation.

 

Ms. Nelly Staderini

Since more than 3 years, Nelly Staderini is in charge of the  Sexual and Reproductive Health and sexual violence in the medical department of Doctors Without Borders in Geneva. After initial training in midwifery and a Public Health Diploma in France, she practiced  in Parisian hospitals and had various functions in humanitarian missions abroad ( Mali , Cambodia, Pakistan, Afghanistan, Guinea , Chad and Burundi ) for non -governmental organizations. She has worked on maternal health issues in general and sexual violence, prevention and treatment of obstetric fistula and the prevention of mother to child transmission of HIV in particular. She is the author of academic works dealing with training of TBAs in Cambodia and midwives in Chad as well as two books: Sage-femme en Afghanistan (Cheminements Editions , 2003) and l' art revisité des matrones, naissances contemporaines en question ( Faustroll Edition, 2011).

GHF2014 – LS02 – Evidence Informed Decision Making in Achieving UHC: the Role of Macro HTA

12:15
13:45
LS02 TUESDAY, 15 APRIL 2014 ROOM: 3
LUNCH
SESSION
Evidence Informed Decision Making in Achieving UHC:
the Role of Macro HTA

SPEAKERS:
Dr. Nick Drager
Honorary Professor, Senior Fellow, Global Health Programme, The Graduate Institute, Geneva
Mr. Adrian Griffin
Vice President, HTA Policy, Johnson & Johnson
Dr. Franz Pichler
Director, Global Public Policy, Eli Lilly and Company
Dr. John-Arne Røttingen
Norwegian Knowledge Centre for the Health Services
Dr. Eva Maria Ruiz de Castilla
Executive Director, Esperantra (NPO, Peru)
OUTLINE:

As a number of countries aspire to implement universal health coverage frameworks, many are looking at methods to best structure their health system to ensure citizens obtain the health services they need. Given cost constrained environments, many low and middle income countries have increasingly focused efforts on prioritization and determining value for investments in health. As such, a significant focus has turned towards the use of research evidence as a tool to support decision making. However, historically, this type of evidence has rarely been applied to support overall health system decision making. In the context of developed countries, a narrow interpretation has placed a significant emphasis on decisions related to coverage and reimbursement of healthcare technologies, such as medicines and diagnostics. 1 Healthcare technologies are only one of several inputs in the overall health system. The organization and delivery of a health care system is a complex matter, which requires a number of decisions regarding the resources necessary to ensure access to services, the mix of interventions required and the means to achieve optimal results.2 Limiting evidence based decision making to coverage decisions tends to obscure the potential role to apply to the overall health system as a whole, such as interventions that facilitate access, service delivery, and aim to improve quality of care.

Therefore, as countries embark towards universal health coverage, it is important that decisions related to coverage of health products and benefits packages are only one part of the discussion. Many low and middle income countries have extensive inefficiencies in their health systems, including issues related to service delivery, quality of care and treatment standards that transcend the need to focus specifically on coverage of health technologies to determine value for investments in health.

This session will explore the role of evidence informed decision making in achieving universal health coverage, looking specifically at the role of "macro" HTA as it is applied to overall health system efficiency and quality of care. This unique session will provide the audience with a view of different perspectives from various sectors in the healthcare space - patient, industry, academic and payer/NGO. Through live interaction, the audience will be able to participate and provide thought provoking questions/answers amongst the group to explore this innovative topic.

PROFILES:

Nick Drager M.D., Ph.D
Honorary Professor, Senior Fellow, Global Health Programme, The Graduate Institute, Geneva

Former Director of the Department of Ethics, Equity, Trade and Human Rights and Senior Adviser in the Strategy Unit, Office of the Director-General at the World Health Organization- now is Honorary Professor, Global Health Policy, London School of Hygiene & Tropical Medicine; Professor of Practice, Public Policy and Global Health Diplomacy, McGill University; Adjunct Professor, Department of Epidemiology and Community Medicine, University of Ottawa; Adjunct Research Professor, Norman Paterson School of International Affairs, Ottawa; and Senior Fellow, Global Health Programme, The Graduate Institute, Geneva.

  • Work focuses on current and emerging issues related to global health, in the areas of global health security/diplomacy/governance, foreign policy and international trade and health including intellectual property and health.
  • Extensive experience working with senior officials in over 100 countries and major multilateral and bilateral development agencies in health policy development, health sector analysis, strategic planning and resource mobilization and allocation decisions and in providing strategic advice on health development negotiations and in conflict resolution.
  • Deep experience in global health diplomacy and high-level negotiations on international health security and development issues.
  • Represented WHO, serves as chair, keynote speaker at major international events and conferences; lectures and teaches at Universities in Europe, North America and Asia.
  • Editor/author of books, papers and editorials in the area of global health; global health diplomacy; trade and health including IP; foreign policy and health. Has an M.D. from McGill University and a Ph.D. in Economics from Hautes Etudes Internationales, (the Graduate Institute) University of Geneva.

 

AdrianGriffinAdrian Griffin
Vice President, HTA Policy, Johnson & Johnson

Adrian Griffin is Vice President, HTA & Market Access Policy at Johnson & Johnson.  He has been involved in the fields of health economics, outcomes research, and reimbursement policy within the healthcare industry for 16 years, with experience across the pharmaceutical, medical device, and diagnostic sectors.

Mr Griffin graduated in Medicinal Chemistry from University College London, obtained a post-graduate teaching qualification from Oxford University, and spent several years teaching chemistry before joining the UK’s Medical Research Council.  He then received his MSc in Health Economics at City University, London, before joining the healthcare industry.  Mr Griffin has held positions at GlaxoSmithKline, Pharmacia, and most recently Johnson & Johnson, where he has been since 2003.

In addition to undertaking outcomes research from the industry perspective, Mr Griffin has also served as a ‘decision-maker’, on the NICE Technology Appraisal Committee, where he has been a committee member for 10 years.  Mr Griffin is also active in numerous multi-stakeholder forums where key issues of HTA and access policy are debated and shaped, such as the HTAi Policy Forum, and initiatives that have brought regulators and HTA agencies together with companies, thus improving transparency and appreciation of different stakeholder perspectives.

Mr Griffin has contributed to several UK industry-government task-force and working groups, aimed at developing policy and processes to improve equitable access and uptake for patients to new innovations.

Within Europe, Mr Griffin has engaged through Company and Industry Association activities with EUnetHTA, with the aim of ensuring that what comes out of HTA collaboration across Europe is fit for purpose, with the ultimate aim of improving healthcare for patients.

Mr Griffin is currently on the Board of Directors of ISPOR, (the International Society for Pharmacoeconomics and Outcomes Research), and continues in his position as a member of the NICE Technology Appraisals Committee

 

Franz_Pichler2Franz Pichler, PhD
Director, Global Public Policy, Eli Lilly and Company

Franz Pichler has been Director, Global Public Policy at Eli Lilly and Company since 2012. This role encompasses development of external policy positions; provision of strategic advice; and external engagement around policy-related issues. A key focus of the role relates to the European environment, in particular with regards to Health Technology Assessment (HTA) and market access. He represents Lilly on the EuropaBio HTA and Market Access Group and the EFPIA HTA Task Force Steering Committee. He participates in the EUnetHTA Stakeholder Advisory Groups related to relative effectiveness assessment and methodological guidelines development. He is co-chair of the Medicines Adaptive Pathways to Patients initiative and is a participant of the Innovative Medicines Initiative (IMI) project ‘Incorporating real-life clinical data into drug development’ (GetREAL). He was a founding member of the HTAi interest sub group on HTA-Regulatory Interactions which he currently chairs. Franz joined Lilly after serving as the manager of the HTA Programme at the Centre for Innovation in Regulatory Science (CIRS) – a non-profit, independent medicines policy and research think tank. Prior to joining CIRS, Franz worked for over 10 years in molecular biology with specialties in functional genomics, population genetics and bioinformatics. He obtained his BSC in biology and PhD in population genetics at the University of Auckland in 1997 and 2002 respectively.

 

John_Arne_Rottingen_squareDr. John-Arne Røttingen
Norwegian Knowledge Centre for the Health Services

John-Arne Røttingen is Director of the Division of Infectious Disease Control at the Norwegian Institute of Public Health; Professor of Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, Faculty of Medicine, University of Oslo; Visiting Professor at the Department of Global Health and Population, Harvard School of Public Health; and Institute Visiting Scholar at the Harvard Global Health Institute.

He is Associate Fellow at the Centre on Global Health Security, Chatham House; research associate of the European Observatory on Health Systems and Policies; Chair of the Board of the Alliance for Health Policy and Systems Research; member of the Scientific Oversight Group of the Institute for Health Metrics and Evaluation, University of Washington, Seattle; and member of the International Advisory Committee for the Global Burden of Disease study.

He has been Director General of the Norwegian Knowledge Centre for the Health Services; Oxford Scholar at Wadham College; and Fulbright Fellow at Harvard Kennedy School.

He received his MD and PhD from the University of Oslo, an MSc from Oxford University and an MPA from Harvard University.

 

EvaMaria_Ruiz_de_CastillaEva Maria Ruiz de Castilla, PhD
Executive Director, Esperantra (NPO, Peru)

Dr. Eva Maria Ruiz de Castilla is a co-founder and since 2006 Executive Director of ESPERANTRA, a not-for-profit cancer and chronic disease patient advocacy organization in Lima, Peru. Her work at Esperantra is to improve the quality of life of patients with chronic conditions, health promotion, and to advance the recognition of the rights of patients to achieve access to timely diagnosis, treatment, and follow-up care. She has been instrumental in a number of national initiatives focused on cancer, including the government’s Plan Esperanza launched in 2012 to provide basic cancer care coverage for the poorest and most vulnerable Peruvians.

In addition to her work with Esperantra, Dr Ruiz de Castilla consults part-time for various Peruvian ministries, including Health, Social Development, Housing, Women, and Water-Sanitation to help design and coordinate the country’s public-sector social assistance programs. From 2011 to 2012, Dr Ruiz de Castilla was Director General of the Peruvian Ministry of Health’s (MINSA) International Coordination office and before that served as MINSA’s Director General of Health Prevention and Promotion. She has in-depth experience working with donor country agencies and multilateral organizations such as the World Bank.

As a Board Member of the International Alliance of Patients’ Organizations (IAPO) since 2010, Dr Ruiz de Castilla has been a global leader in patient-based organizational capacity building and has led various workshops on patient empowerment and networking. Her experience and involvement with building the capacity of civil society organizations focused on cancer in Peru earned her the American Cancer Society’s “Excelencia Latina 2009” Award. In 2011, Dr Ruiz de Castilla was named a Global Cancer Ambassador by the American Cancer Society, and was invited by the World Health Organization to participate as a civil society representative during the UN High-Level Meeting on non-communicable diseases (NCDs).

Dr Ruiz de Castilla’s academic credentials include degrees in Industrial Engineering and a PhD in Economic Development at the EHESS in Paris, France, and in Political Science at the Sorbonne University Paris 1. In Europe, she consulted for the United Nations on food and agriculture issues for the southern common market (MERCOSUR). Dr Ruiz de Castilla has authored a number of publications and papers on social development, health, and citizen engagement, and has been invited to speak at more than 200 national and international congresses.

GHF2014 – PS05 – Health Services Integration and Disease Control Programmes

10:45
12:15
PS05 TUESDAY, 15 APRIL 2014 ROOM: 13 ICON_Fishbowl
Health Services Integration and Disease Control Programmes
MODERATOR:
Marianne Pirard, MD
Educational Coordinator of the Public Health department, Institute of Tropical Medicine, Antwerp, Belgium
SPEAKERS:
Amina Essolbi, MD, MPH,
Senior lecturer Ecole Nationale de Santé Publique, Rabat, Morocco
Basile Keugoung, MD, MPH, PhD student,
Ministry of Public Health, Yaounde, Cameroon
Raoul Bermejo, MD, MPH, PhD student,
Researcher, Department of Clinical Epidemiology, University of the Philippines College of Medicine, Philippines
OUTLINE:
There is currently a broad consensus in the global community on the need for Health Systems Strengthening (HSS) to make further progress toward the Millennium Development Goals. The recent momentum around UHC, a likely post-MDG goal, is another example of this. However, there is still divergence on how HSS should be framed and how it should be done in practice.In this session we will present three frameworks to guide HSS with applied examples from different countries. We intend to discuss the relevance of these HSS frameworks and exchange experiences in HSS with a diverse audience bringing the perspective from actors such as first line health workers, health system and disease control programme managers, decision makers, international organisations and donors working in diverse settings (LICs & MICs, different continents).
PROFILES:

Marianne Pirard
Marianne Pirard
is a medical doctor with an MPH from the Institute of Tropical Medicine (ITM), Antwerp. She currently is the Educational Coordinator of the Public Health department of ITM and is in charge of the organization of an international MPH with a track in Health Systems & Policy and a track in Disease Control.Before joining ITM in 2002, she worked for 5 years as a clinician in a rural district in Zimbabwe in a period its health system based on PHC principles was an example for the region (1986-91). She also spent 8 years in Bolivia as a Public Health physician, strengthening the National Centre for Tropical Diseases in its operational research and surveillance activities. (1994-2002)She believes that stronger synergies between health service managers and disease control programme managers can make health systems stronger.

 

Amina Essolbi

Amina Essolbi is a medical doctor with an MPH from Boston University.
She has worked for 5 years as medical officer before being recruited by USAID-Morocco as health care specialist (1994-98).
Thereafter, she joined the National School of Public Health (ENSP) in Morocco where she is a lecturer. She also teaches in different national and international short courses (VIH-AIDS, Ipact, continuing education) on matters related to strategic planning, project management, epidemiology and disease surveillance.

Her current domain of research is related to the role of home caregivers, the effects of free health care policies on the local health system and the conditions and mechanisms of success or failure of policy implementation.

 

Basile Keugoung

Basile Keugoung is a medical doctor, with a Master in Public Health in Health system management and policy from the Institute of Tropical Medicine, Antwerp-Belgium. He is registered as a PhD candidate at the Louvain Catholic University, Brussels-Belgium since 2010. He has a 10-year experience of working as a district medical officer in Cameroon. He is also co-facilitator of the Community of Practice Health Service Delivery (https://hhacops.org/cop-hsd-pss-bilingual/), and one of the Editors of the Newsletter ‘Politiques Internationales de Santé (www.santemondiale.org). His field of research is the interface between vertical programmes and the general health system. The aim is to find avenues for optimizing the interface between vertical programmes and the recipient health system.

 

Raoul Bermejo

Raoul Bermejo III, MD, MPH

Researcher, Department of Clinical Epidemiology, University of the Philippines College of Medicine.

PhD Student at the Institute of Tropical Medicine, Antwerp, Belgium.

He is a medical doctor with experience in managing Reproductive, Maternal, and Child Health and Nutrition Programs in the Philippines. He also worked as a consultant for the Philippine Health Insurance Corporation. His current research work is focused on understanding how health systems in low and middle income countries are adapting to the rise in the burden of non-communicable diseases. He is also interested in global and local discussions on UHC.

When he is not thinking about global health problems, he dives and restores traditional Ifugao houses.

GHF2014 – PL02 – Integrated Health Systems in a Pluralistic and Fast Changing Environment

08:45
10:15
PL02 WEDNESDAY, 16 APRIL 2014 ROOM: 2 ICON_QA
INTEGRATED HEALTH SYSTEMS IN A PLURALISTIC AND FAST CHANGING ENVIRONMENT
MODERATOR:
Prof. Don de Savigny
Head, Health Systems Interventions Research Unit, Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Switzerland
PANEL:
Prof. Recep Akdağ
Former Minister of Health of Turkey between 2002 and 2013, Turkey
Mr. Jacques Mader
Regional Health Advisor, Swiss Agency for Development and Cooperation, Switzerland
Prof. Manoris Meshack
Team Leader, Health Promotion System Strengthening Project in Dodoma, Tanzania
Dr. David B. Evans
Director, Department of Health Systems Financing, World Health Organization, Switzerland
AIM:
Discuss the drivers and enabling factors that determine health systems ‘ability to better integrate their critical functions.
OUTLINE:
The World Health Organization (WHO) defines health systems as all organizations, people, and actions whose primary intent is to promote, restore, or maintain health. An effective health system is a core institution, no less important than a fair justice system or democratic political system. Depending how they are designed and governed health systems can empower people thus alleviating suffering or further exclude them, deepening inequity and worsening the experience of poverty. Strong and equitable health systems contribute to the progress toward universal health coverage and sustainable development. In a context of profound demographic and epidemiological changes and highly pluralistic environments characterized by multiple public and private providers, the integration of the various activities, resources and actors that are shaping health systems remains a challenge.Drawing on the experiences three countries pursuing reforms to achieve universal health coverage (UHC) and the personal journeys of actors involved in health system development, this session will aim to discuss the contextual drivers and factors that are shaping health systems transformation towards universal health coverage.
PROFILES:

Don de Savigny_squareProf. Don de Savigny

Professor de Savigny is an epidemiologist and public health specialist and currently Head of the Health Systems Research Unit in the Department of Epidemiology and Public Health at the Swiss Tropical and Public Health Institute, University of Basel.  He has extensive experience in conducting and facilitating health research in developing countries and has lived and worked for many years in Africa.  He chairs or is a member of a number of WHO, RBM, Global Fund, and TDR advisory committees and networks such as COHRED, the Health Metrics Network and the INDEPTH Network.  His current research focuses on interventions to strengthen health systems in developing countries, and on the health system effects of Global Health Initiatives for scaling up access.

 

RecepAkdagSquareProf. Recep Akdağ, Turkey

Recep Akdag was born in Erzurum, Turkey in 1960. As a pediatrician, he has been holding a professor title from the Ataturk University School of Medicine since 1999. During his career as a medical specialist and academician, he had been involved in a number of administrative tasks. Between 1994 and 1998, he worked as the Deputy Chief Medical Director, Chairman of the Procurement Commission and Deputy Editor of the Medical Bulletin in the Research Hospital of the Medical Faculty of Ataturk University. He also co-founded the Biotechnology Research Center of the University and served as the Deputy Head of the Center from 1997 to 2000. (Read more...)

 

jacques Mader_squareMr. Jacques Mader

Jacques Mader has several decades of multifaceted experience of the health sector in various positions. He’s always been more of a practitioner than a theoretician, more of a (critical) user than a producer of research results. Over the years and thanks to his practice in a great variety of contexts he has become increasingly pragmatic. He strives to use his expertise to promote equity in the access to health resources as well as a broader approach on the determinants of health.

 

Prof. Manoris Meshack

Manoris Meshack was a Team leader of a component of Tanzania Essential Health Project in Developing a community based approach for rehabilitation for Health facilities for Morogoro and Rufiji; after successful completion of the two regions was tasked to roll out the plan to the whole country. Trained District teams and village teams of the same districts and supervised the implementation which was very successful both by constructing the facilities, developing a sustainable maintenance system and reduction of costs. Thereafter Lead a multidisciplinary team for developing, training and implementation  a countrywide approach on community infrastructure rehabilitation in the process rolling out of the approach, to the whole country on the same approach.

From 2001 he was founder member for initiating Tanzania network for Community Health Funds and was the first Secretary General of the Network until he retired in 2006.

He also acted as consultant in Dar es salaam Urban Health Project; he acted as facilitator in Lake Victoria Basin Development program and operated in East African contest.

Manoris Meshack has been Deputy Vice Chancellor Planning and Finance latter promoted to Vice Chancellor Academics. He was appointed to start a New University and acted for one 1year as Project leader before he was appointed to the post of Vice Chancellor until the completion of his term. From 06/2011 to date Manoris Meshack has been employed  as a Team leader of Health Promotion System Strengthening project in Dodoma.

 

David_evansDr. David B. Evans

David B. Evans, Director of the Department of Health Systems Financing in the Cluster on Health Systems and Services at WHO, has a PhD in economics and worked as an academic and consultant in Australia and Singapore before joining WHO in 1990. His work has covered the social and economic aspects of tropical disease control, the assessment of health system performance and the generation, analysis and use of evidence for health policy. His current responsibility is the development of effective, efficient and equitable health financing systems, through technical support to countries, generation and use of evidence, capacity strengthening and partnership with other development agencies and initiatives. He was the lead author for the World Health Report 2010 (Health Systems Financing: the Path to Universal Coverage).

 

 

 

GHF2014 – PS29 – Information and Communication to Promote and Facilitate Health

10:45
12:15
PS29 THURSDAY, 17 APRIL 2014 ROOM: LEMAN
ICON_QA
Information and Communication to Promote and Facilitate Health
MODERATOR:
Prof. L. Suzanne Suggs, PhD, MS, CHES, Senior Assistant Professor of Social Marketing and Head of BeCHANGE Research Group, Institute for Public Communication (ICP), Faculty of Communication Sciences, Università della Svizzera italiana, Switzerland
SPEAKERS:
Smartphones to Improve Health Workers Performance and Rational of Drug Use for Management of Childhood Illnesses in a Low Resource Settings
Ms. Clotilde Rambaud-Althaus, MD, PhD candidate, Epidemiology and Public Health Department, Swiss Tropical and Public Health Institute, Switzerland
Prof. Don de Savigny
Head, Health Systems Interventions Research Unit, Department of Public Health and Epidemiology, Swiss Tropical and Public Health Institute, Switzerland
Dr. Allison Goldberg
Director, Global Corporate Affairs, Global Corporate Affairs Anheuser-Busch InBev, United States
Dr. Anthony Adoghe
Research PhD student in Public Health at the University of Essex and founder of Adoghes’ Online Public Health Clinic, United Kingdom
Ms. Sabina Beatrice-Matter
Manager Health Projects, Novartis Foundation for Sustainable Development Switzerland
OUTLINE:
PROFILES:

Suggs photo_sept 2011Prof. L. Suzanne Suggs

Professor Suggs is an Assistant Professor of Social Marketing and Head of the BeCHANGE Research Group in the Institute for Public Communication, Faculty of Communication Sciences, at the Università della Svizzera italiana (USI), in Lugano Switzerland. She is also Director of the USI Sustainability Incubator (USI-SINC). She received a BBA in Marketing at University of North Texas (USA), a MSc and PhD in Health Studies at Texas Woman’s University (USA), and a Post-doctoral fellowship at McMaster University (Canada).

Suzanne’s research focuses on behavior change communication through information and communication technologies. She examines the determinants of behavior and tests innovative digital communication strategies, delivered through ICT, and the influence on health behaviors. The majority of her work focuses on eating and physical activity behaviors, but also does research on alcohol, tobacco, decision-making, vaccination uptake, hand washing, HIV testing, medication compliance, self-management of conditions and therapy, and consumption behaviors.

Prior to joining the faculty in Lugano, she was Assistant Professor of Health Communication, Department of Marketing Communication, at Emerson College and Adjunct Assistant Clinical Professor in the Department of Public Health and Family Medicine at Tufts University School of Medicine (Boston, Massachusetts, USA). She has a wealth of industry experience, working with pharmaceutical companies, health insurers, foundations, organizations, and multi-media communication companies. She is a Co-Founder and on the Executive Board of the European Social Marketing Association and is on the Editorial Board for the Journal of Health Communication: International Perspectives. She teaches graduate level courses in Social Marketing, Focus Group Methods, Research Methods, and Media Skills. And for the second year in a row, Suzanne will teach a course on ” m-Health: Mobile Communication for Public Health”, in the Swiss School of Public Health+ Summer School this August in Lugano.

Rambaud Profile PhotoMs. Clotilde Rambaud-Althaus

Married, mother of two girls and MD, specialist in General Medicine (France), with a focus on Tropical Medicine and International Health. Large field experience as clinician or research scientist with Médecins Sans Frontières and Epicentre in Democratic Republic of Congo, Lebanon, Central African Republic, Cameroun, and Swaziland. Back in Switzerland after three years of expatriation in Tanzania, from 2010 to 2012 as PhD Student with Swiss Tropical and Public Health Institute and University of Basel in the field of malaria, non-malarial fever, and management of childhood illnesses. Currently finishing a PhD thesis and working as a clinician in Travel Medicine Unit of University Hospital of Lausanne.

Don de Savigny_squareProf. Don de Savigny

Professor de Savigny is an epidemiologist and public health specialist and currently Head of the Health Systems Research Unit in the Department of Epidemiology and Public Health at the Swiss Tropical and Public Health Institute, University of Basel.  He has extensive experience in conducting and facilitating health research in developing countries and has lived and worked for many years in Africa.  He chairs or is a member of a number of WHO, RBM, Global Fund, and TDR advisory committees and networks such as COHRED, the Health Metrics Network and the INDEPTH Network.  His current research focuses on interventions to strengthen health systems in developing countries, and on the health system effects of Global Health Initiatives for scaling up access.

Goldberg_Badge_squareDr. Allison Goldberg

Allison Goldberg is a recognized public health expert who has worked with private and public sector leaders around the world on topics ranging from HIV/AIDS to maternal and child health, health innovation scale-up, and health systems strengthening. Allison has published widely and presented on these topics at national and international conferences and high-level meetings with the United States Government and United Nations. Allison spent eight years working with consumer health and pharmaceutical companies, health providers, national and local governments, and non-governmental organizations all sharing interests in developing and implementing evidence-based solutions to address global health challenges. Allison is currently the Director, Global Corporate Affairs, Anheuser-Busch InBev (ABI). In this role, Allison manages and helps develop ABI’s evidence-based research approach to advancing prudent policy related to alcohol and global health. She manages a portfolio of public health initiatives and ensures that research and best practices are embedded in these initiatives. Allison earned a B.A. in Political Science from the University of Michigan, Ann Arbor and an interdisciplinary Ph.D. in Public Health and Political Science from Columbia University.

SabinaMs. Sabina Beatrice-Matter

Sabina Beatrice-Matter is Project Manager at the Novartis Foundation for Sustainable Development for some of the foundation’s healthcare projects, namely the primary healthcare program in Mali, the Tanzanian Training Centre for International Health as well as ICATT and IMPACtt – two eLearning initiatives aimed at improving training in maternal, newborn and child health in collaboration with WHO and the Swiss Tropical and Public Health Institute. From 2008 to 2013, Sabina was also in charge of Communication’s at the Novartis Foundation. Prior to joining the foundation, Sabina worked for the communications department at Novartis and did internships with the Swiss national television in Berne and the news agency FSN in Washington DC.

Sabina is currently doing an MBA in International Health Management at the University of Basel (graduation expected in 2015). She holds a Master’s degree in International Relations from the Graduate Institute of International and Development Studies in Geneva and the University of Salamanca in Spain and studied one year of Journalism at the Shenandoah University, USA.

GHF2014 – PS26 – The Potential of One Health and EcoHealth Approaches to Health and Wellbeing

10:45
12:15
PS26 THURSDAY, 17 APRIL 2014 ROOM: MOTTA
ICON_Fishbowl
The Potential of One Health and EcoHealth Approaches to Health and Wellbeing
MODERATOR:
Dr. Jacob Zinsstag
Professor, PhD, DVM, Group Leader, Head of Unit , Swiss Tropical & Public Health Institute, Switzerland
SPEAKERS:
Prof. Bassirou Bonfoh
Director of the Swiss Centre for Scientific Research (CSRS) Abidjan, Ivory Coast
Dr. Margot Parkes
Canada Research Chair in Health, Ecosystems and Society, University of Northern British Columbia, Canada
Dr. Maya K. Gislason
Associate Researcher, Centre for Global Health Policy, University of Sussex, UK
Postdoctoral Fellow, School of Health Sciences, University of Northern British Columbia, Canada
Dr. Esther Schelling
Mobile populations and Health, Swiss TPH, Switzerland
OUTLINE:
One Health and EcoHealth are new concepts. Many people use the terms but often without knowing what they mean. This session will present key examples of One Health and Ecohealth approaches, demonstrating the added value of closer cooperation between human and animal health sectors in terms of health and wellbeing of humans and animals. Human health is inextricably linked to intact ecosystems, yet we overuse and destroy them in a way which increasingly affects our health. Health and ecosystem integrity have to be considered together. This requires participatory transdisciplinary approaches of negotiation of trade-offs between different perspectives. Transdisciplinary approaches are inherent to One Health and Ecohealth approaches and this session will provide a unique opportunity for the broader understanding of the concepts and future orientation of research in Switzerland and globally.
PROFILES:

Dr. Jacob Zinsstag

Jakob Zinsstag graduated with a doctorate in veterinary medicine (Dr. med. vet.) on Salmonella diagnosis at the Veterinary Faculty of the University of Berne in 1986. After his studies he worked in rural practice and as post doctoral fellow on trypanosomiasis research at the Swiss Tropical Institute. From 1990 to end of 1993 he led a livestock helminthosis project for the University of Berne at the International Trypanotolerance Centre in The Gambia. From 1994 to 1998 he directed the Centre Suisse de Recherches Scientifiques in Abidjan, Côte d’Ivoire. Since 1998 he leads a research group at the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel on the interface of human and animal health with a focus on health of nomadic people and control of zoonoses in developing countries under the paradigm of  “one medicine”. He holds a PhD in Tropical Animal Production from the Prince Leopold Institute of Tropical Medicine of Antwerp, Belgium. Since 2004 he is Assistant Professor and since 2010 Professor of Epidemiology at the University of Basel. He is a diplomate of the European College of Veterinary Public Health (ECVPH) and member of the scientific advisory board of the Prince Leopold Institute of Tropical Medicine of Antwerp, Belgium. Jakob Zinsstag has been elected president of the International Association for Ecology and Health in 2012.